Certain Radio Frequency Micro-Needle Dermatological Treatment Devices and Components Thereof; Institution of Investigation, 22515-22516 [2018-10240]

Download as PDF daltland on DSKBBV9HB2PROD with NOTICES Federal Register / Vol. 83, No. 94 / Tuesday, May 15, 2018 / Notices the Office of Surface Mining Reclamation and Enforcement (OSMRE) are proposing to renew an information collection for the Excellence in Surface Coal Mining Reclamation Award and the Abandoned Mine Land Reclamation Awards. These awards have been established to give well-earned public recognition to those responsible for the nation’s highest achievements in abandoned mine land reclamation, and who have developed innovative reclamation techniques or who have completed reclamation that resulted in outstanding on-the-ground performance. DATES: Interested persons are invited to submit comments on or before June 14, 2018. ADDRESSES: Send written comments on this information collection request (ICR) to the Office of Management and Budget’s Desk Officer for the Department of the Interior by email at OIRA_Submission@omb.eop.gov; or via facsimile to (202) 395–5806. Please provide a copy of your comments to John Trelease, Office of Surface Mining Reclamation and Enforcement, 1849 C. Street NW, Mail Stop 4559, Washington, DC 20240; or by email to jtrelease@ osmre.gov. Please reference OMB Control Number 1029–0039 in the subject line of your comments. FOR FURTHER INFORMATION CONTACT: To request additional information about this ICR, contact John Trelease by email at jtrelease@osmre.gov, or by telephone at (202) 208–2783. You may also view the ICR at http://www.reginfo.gov/ public/do/PRAMain. SUPPLEMENTARY INFORMATION: In accordance with the Paperwork Reduction Act of 1995, we provide the general public and other Federal agencies with an opportunity to comment on new, proposed, revised, and continuing collections of information. This helps us assess the impact of our information collection requirements and minimize the public’s reporting burden. It also helps the public understand our information collection requirements and provides the requested data in the desired format. A Federal Register notice with a 60day public comment period soliciting comments on this collection of information was published on January 31, 2018 (83 FR 4514). No comments were received. We are again soliciting comments on the proposed ICR that is described below. We are especially interested in public comment addressing the following issues: (1) Is the collection necessary to the proper functions of OSMRE; (2) is the estimate of burden accurate; (3) how might OSMRE VerDate Sep<11>2014 20:27 May 14, 2018 Jkt 244001 enhance the quality, utility, and clarity of the information to be collected; and (4) how might OSMRE minimize the burden of this collection on the respondents, including through the use of information technology. Comments that you submit in response to this notice are a matter of public record. Before including your address, phone number, email address, or other personal identifying information in your comment, you should be aware that your entire comment—including your personal identifying information—may be made publicly available at any time. While you can ask us in your comment to withhold your personal identifying information from public review, we cannot guarantee that we will be able to do so. Title: Reclamation Awards—Call for Nominations. OMB Control Number: 1029–0129. Abstract: This information collection clearance package is being submitted by the Office of Surface Mining Reclamation and Enforcement (OSMRE) for renewed approval to collect information for our annual call for nominations for our Excellence in Surface Coal Mining Reclamation Awards and Abandoned Mine Land Reclamation Awards. Since 1986, the Office of Surface Mining has presented awards to coal mine operators who completed exemplary active reclamation. A parallel award program for abandoned mine land reclamation began in 1992. The objective is to give public recognition to those responsible for the nation’s most outstanding achievement in environmentally sound surface mining and land reclamation and to encourage the exchange and transfer of successful reclamation technology. This collection request seeks a three-year term of approval. Form Number: None. Type of Review: Extension of a currently approved collection. Respondents/Affected Public: Industry and state/tribal nominees for reclamation awards and state/tribal reviewers and judges. Total Estimated Number of Annual Respondents: 14 active mine respondents, 11 abandoned mine land state/tribal respondents, and 40 state and tribal reviewers and judges. Total Estimated Number of Annual Responses: 65. Estimated Completion Time per Response: An average of 17 hours per coal producer, 67 hours per State/Tribal nominee, and 2 hours to 8 hours per State/Tribe to judge responses. Total Estimated Number of Annual Burden Hours: 1,211 hours. PO 00000 Frm 00075 Fmt 4703 Sfmt 4703 22515 Respondent’s Obligation: Voluntary. Frequency of Collection: One time. Total Estimated Annual Nonhour Burden Cost: $2,500. An agency may not conduct or sponsor and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. The authority for this action is the Paperwork Reduction Act of 1995 (44 U.S.C. 3501 et seq.). John A. Trelease, Acting Chief, Division of Regulatory Support. [FR Doc. 2018–10278 Filed 5–14–18; 8:45 am] BILLING CODE 4310–05–P INTERNATIONAL TRADE COMMISSION [Investigation No. 337–TA–1112] Certain Radio Frequency Micro-Needle Dermatological Treatment Devices and Components Thereof; Institution of Investigation U.S. International Trade Commission. ACTION: Notice. AGENCY: Notice is hereby given that a complaint was filed with the U.S. International Trade Commission on April 9, 2018, under section 337 of the Tariff Act of 1930, as amended, on behalf of Syneron Medical Ltd. of Israel; Candela Corporation of Wayland, Massachusetts; and Massachusetts General Hospital of Boston, Massachusetts. A supplement was filed on April 27, 2018. The complaint, as supplemented, alleges violations of section 337 based upon the importation into the United States, the sale for importation, and the sale within the United States after importation of certain radio frequency micro-needle dermatological treatment devices and components thereof by reason of infringement of certain claims of U.S. Patent No. 9,510,899 (‘‘the ’899 patent’’) and U.S. Patent No. 9,095,357 (‘‘the ’357 patent’’). The complaint further alleges that an industry in the United States exists as required by the applicable Federal Statute. The complainants request that the Commission institute an investigation and, after the investigation, issue a limited exclusion order and cease and desist orders. ADDRESSES: The complaint, as supplemented, except for any confidential information contained therein, is available for inspection during official business hours (8:45 a.m. to 5:15 p.m.) in the Office of the SUMMARY: E:\FR\FM\15MYN1.SGM 15MYN1 22516 Federal Register / Vol. 83, No. 94 / Tuesday, May 15, 2018 / Notices Secretary, U.S. International Trade Commission, 500 E Street SW, Room 112, Washington, DC 20436, telephone (202) 205–2000. Hearing impaired individuals are advised that information on this matter can be obtained by contacting the Commission’s TDD terminal on (202) 205–1810. Persons with mobility impairments who will need special assistance in gaining access to the Commission should contact the Office of the Secretary at (202) 205– 2000. General information concerning the Commission may also be obtained by accessing its internet server at https://www.usitc.gov. The public record for this investigation may be viewed on the Commission’s electronic docket (EDIS) at https://edis.usitc.gov. FOR FURTHER INFORMATION CONTACT: Katherine Hiner, Office of the Secretary, Docket Services Division, U.S. International Trade Commission, telephone (202) 205–1802. SUPPLEMENTARY INFORMATION: daltland on DSKBBV9HB2PROD with NOTICES Authority: The authority for institution of this investigation is contained in section 337 of the Tariff Act of 1930, as amended, 19 U.S.C. 1337 and in section 210.10 of the Commission’s Rules of Practice and Procedure, 19 CFR 210.10 (2017). Scope of Investigation: Having considered the complaint, the U.S. International Trade Commission, on May 9, 2018, Ordered that— (1) Pursuant to subsection (b) of section 337 of the Tariff Act of 1930, as amended, an investigation be instituted to determine whether there is a violation of subsection (a)(1)(B) of section 337 in the importation into the United States, the sale for importation, or the sale within the United States after importation of certain radio frequency micro-needle dermatological treatment devices and components thereof by reason of infringement of one or more of claims 1, 2, 4, 9–11, 15, 20, and 21 of the ’899 patent and claims 1, 2, 4, 9–12, 17, and 18 of the ’357 patent, and whether an industry in the United States exists as required by subsection (a)(2) of section 337; (2) For the purpose of the investigation so instituted, the following are hereby named as parties upon which this notice of investigation shall be served: (a) The complainants are: Syneron Medical Ltd., Tavor Building, Industrial Zone, Yokneam lllit, 20692, Israel Candela Corporation, 530 Boston Post Road, Wayland, MA 01778 General Hospital Corporation d/b/a, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 VerDate Sep<11>2014 20:27 May 14, 2018 Jkt 244001 (b) The respondents are the following entities alleged to be in violation of section 337, and are the parties upon which the complaint is to be served: Invasix, Inc., 21084 Bake Parkway, Suite 106, Lake Forest, CA 92618 Invasix, Ltd., Apolo Building, Shaar Yokneam, Yokneam, 20692, Israel Inmode Md, Ltd., 20996 Bake Parkway, Suite 106, Lake Forest, CA 92630 Ilooda Co., Ltd., 37–1 Imok-dong, Imokdong, Jangan-gu, Suwon-si, Gyeonggido, Republic of Korea Cutera, Inc., 3240 Bayshore Boulevard, Brisbane, CA 94005 Emvera Technologies, LLC, 641 10th Street, Cedartown, GA 30125 Rohrer Aesthetics, LLC, 105 Citation Court, Homewood, AL 35209 Lutronic, Corp., Lutronic Center, 219 Sowon-ro, Deogyang-gu, Goyang-si, Geonggi-do, Republic of Korea Lutronic, Inc., 19 Fortune Drive, Billerica, MA 01821 Endymed Medical Inc., 790 Madison Avenue, Suite 402, New York, NY 10065 Endymed Medical Ltd., 12 Leshem Street, North Industrial Park, Caesarea, 30889 Israel Sung Hwan E&B Co., Ltd. d/b/a SHEnB Co., Ltd., 148 Seongsui-Ro, Soengdong-Gu, Seoul 04796, Republic of Korea Aesthetics Biomedical, Inc., 4602 N 16th Street, Suite 300, Phoenix, AZ 85016 Cartessa Aesthetics, 210 Peoples Way, Hockessin, DE 19707–1904 Jeisys Medical, Inc., 307 Daeryung Techno Town 8th, Gamasan-ro 96, Geumcheon-Gu, Seoul, 153–775, Republic of Korea Perigee Medical LLC, 2227 N Macarthur Dr., Tracy, CA 95376–2830 Lumenis Ltd., Yokneam Industrial Park, Hakidma 6, Yokneam 2069204, Israel Pollogen Ltd., 6 Kaufman Yehezkel, Tel Aviv-Jaffa, 6801298, Israel (3) For the investigation so instituted, the Chief Administrative Law Judge, U.S. International Trade Commission, shall designate the presiding Administrative Law Judge. The Office of Unfair Import Investigations will not participate as a party in this investigation. Responses to the complaint and the notice of investigation must be submitted by the named respondents in accordance with section 210.13 of the Commission’s Rules of Practice and Procedure, 19 CFR 210.13. Pursuant to 19 CFR 201.16(e) and 210.13(a), such responses will be considered by the Commission if received not later than 20 days after the date of service by the Commission of the complaint and the PO 00000 Frm 00076 Fmt 4703 Sfmt 4703 notice of investigation. Extensions of time for submitting responses to the complaint and the notice of investigation will not be granted unless good cause therefor is shown. Failure of a respondent to file a timely response to each allegation in the complaint and in this notice may be deemed to constitute a waiver of the right to appear and contest the allegations of the complaint and this notice, and to authorize the administrative law judge and the Commission, without further notice to the respondent, to find the facts to be as alleged in the complaint and this notice and to enter an initial determination and a final determination containing such findings, and may result in the issuance of an exclusion order or a cease and desist order or both directed against the respondent. By order of the Commission. Issued: May 9, 2018. Lisa Barton, Secretary to the Commission. [FR Doc. 2018–10240 Filed 5–14–18; 8:45 am] BILLING CODE 7020–02–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Bulk Manufacturer of Controlled Substances Application: Patheon API Manufacturing, Inc. ACTION: Notice of application. Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before July 16, 2018. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. DATES: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or SUPPLEMENTARY INFORMATION: E:\FR\FM\15MYN1.SGM 15MYN1

Agencies

[Federal Register Volume 83, Number 94 (Tuesday, May 15, 2018)]
[Notices]
[Pages 22515-22516]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-10240]


=======================================================================
-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Investigation No. 337-TA-1112]


Certain Radio Frequency Micro-Needle Dermatological Treatment 
Devices and Components Thereof; Institution of Investigation

AGENCY: U.S. International Trade Commission.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that a complaint was filed with the 
U.S. International Trade Commission on April 9, 2018, under section 337 
of the Tariff Act of 1930, as amended, on behalf of Syneron Medical 
Ltd. of Israel; Candela Corporation of Wayland, Massachusetts; and 
Massachusetts General Hospital of Boston, Massachusetts. A supplement 
was filed on April 27, 2018. The complaint, as supplemented, alleges 
violations of section 337 based upon the importation into the United 
States, the sale for importation, and the sale within the United States 
after importation of certain radio frequency micro-needle 
dermatological treatment devices and components thereof by reason of 
infringement of certain claims of U.S. Patent No. 9,510,899 (``the '899 
patent'') and U.S. Patent No. 9,095,357 (``the '357 patent''). The 
complaint further alleges that an industry in the United States exists 
as required by the applicable Federal Statute.
    The complainants request that the Commission institute an 
investigation and, after the investigation, issue a limited exclusion 
order and cease and desist orders.

ADDRESSES: The complaint, as supplemented, except for any confidential 
information contained therein, is available for inspection during 
official business hours (8:45 a.m. to 5:15 p.m.) in the Office of the

[[Page 22516]]

Secretary, U.S. International Trade Commission, 500 E Street SW, Room 
112, Washington, DC 20436, telephone (202) 205-2000. Hearing impaired 
individuals are advised that information on this matter can be obtained 
by contacting the Commission's TDD terminal on (202) 205-1810. Persons 
with mobility impairments who will need special assistance in gaining 
access to the Commission should contact the Office of the Secretary at 
(202) 205-2000. General information concerning the Commission may also 
be obtained by accessing its internet server at https://www.usitc.gov. 
The public record for this investigation may be viewed on the 
Commission's electronic docket (EDIS) at https://edis.usitc.gov.

FOR FURTHER INFORMATION CONTACT: Katherine Hiner, Office of the 
Secretary, Docket Services Division, U.S. International Trade 
Commission, telephone (202) 205-1802.

SUPPLEMENTARY INFORMATION: 

    Authority:  The authority for institution of this investigation 
is contained in section 337 of the Tariff Act of 1930, as amended, 
19 U.S.C. 1337 and in section 210.10 of the Commission's Rules of 
Practice and Procedure, 19 CFR 210.10 (2017).

    Scope of Investigation: Having considered the complaint, the U.S. 
International Trade Commission, on May 9, 2018, Ordered that--
    (1) Pursuant to subsection (b) of section 337 of the Tariff Act of 
1930, as amended, an investigation be instituted to determine whether 
there is a violation of subsection (a)(1)(B) of section 337 in the 
importation into the United States, the sale for importation, or the 
sale within the United States after importation of certain radio 
frequency micro-needle dermatological treatment devices and components 
thereof by reason of infringement of one or more of claims 1, 2, 4, 9-
11, 15, 20, and 21 of the '899 patent and claims 1, 2, 4, 9-12, 17, and 
18 of the '357 patent, and whether an industry in the United States 
exists as required by subsection (a)(2) of section 337;
    (2) For the purpose of the investigation so instituted, the 
following are hereby named as parties upon which this notice of 
investigation shall be served:
    (a) The complainants are:

Syneron Medical Ltd., Tavor Building, Industrial Zone, Yokneam lllit, 
20692, Israel
Candela Corporation, 530 Boston Post Road, Wayland, MA 01778
General Hospital Corporation d/b/a, Massachusetts General Hospital, 55 
Fruit Street, Boston, MA 02114

    (b) The respondents are the following entities alleged to be in 
violation of section 337, and are the parties upon which the complaint 
is to be served:

Invasix, Inc., 21084 Bake Parkway, Suite 106, Lake Forest, CA 92618
Invasix, Ltd., Apolo Building, Shaar Yokneam, Yokneam, 20692, Israel
Inmode Md, Ltd., 20996 Bake Parkway, Suite 106, Lake Forest, CA 92630
Ilooda Co., Ltd., 37-1 Imok-dong, Imok-dong, Jangan-gu, Suwon-si, 
Gyeonggi-do, Republic of Korea
Cutera, Inc., 3240 Bayshore Boulevard, Brisbane, CA 94005
Emvera Technologies, LLC, 641 10th Street, Cedartown, GA 30125
Rohrer Aesthetics, LLC, 105 Citation Court, Homewood, AL 35209
Lutronic, Corp., Lutronic Center, 219 Sowon-ro, Deogyang-gu, Goyang-si, 
Geonggi-do, Republic of Korea
Lutronic, Inc., 19 Fortune Drive, Billerica, MA 01821
Endymed Medical Inc., 790 Madison Avenue, Suite 402, New York, NY 10065
Endymed Medical Ltd., 12 Leshem Street, North Industrial Park, 
Caesarea, 30889 Israel
Sung Hwan E&B Co., Ltd. d/b/a SHEnB Co., Ltd., 148 Seongsui-Ro, 
Soengdong-Gu, Seoul 04796, Republic of Korea
Aesthetics Biomedical, Inc., 4602 N 16th Street, Suite 300, Phoenix, AZ 
85016
Cartessa Aesthetics, 210 Peoples Way, Hockessin, DE 19707-1904
Jeisys Medical, Inc., 307 Daeryung Techno Town 8th, Gamasan-ro 96, 
Geumcheon-Gu, Seoul, 153-775, Republic of Korea
Perigee Medical LLC, 2227 N Macarthur Dr., Tracy, CA 95376-2830
Lumenis Ltd., Yokneam Industrial Park, Hakidma 6, Yokneam 2069204, 
Israel
Pollogen Ltd., 6 Kaufman Yehezkel, Tel Aviv-Jaffa, 6801298, Israel

    (3) For the investigation so instituted, the Chief Administrative 
Law Judge, U.S. International Trade Commission, shall designate the 
presiding Administrative Law Judge.
    The Office of Unfair Import Investigations will not participate as 
a party in this investigation.
    Responses to the complaint and the notice of investigation must be 
submitted by the named respondents in accordance with section 210.13 of 
the Commission's Rules of Practice and Procedure, 19 CFR 210.13. 
Pursuant to 19 CFR 201.16(e) and 210.13(a), such responses will be 
considered by the Commission if received not later than 20 days after 
the date of service by the Commission of the complaint and the notice 
of investigation. Extensions of time for submitting responses to the 
complaint and the notice of investigation will not be granted unless 
good cause therefor is shown.
    Failure of a respondent to file a timely response to each 
allegation in the complaint and in this notice may be deemed to 
constitute a waiver of the right to appear and contest the allegations 
of the complaint and this notice, and to authorize the administrative 
law judge and the Commission, without further notice to the respondent, 
to find the facts to be as alleged in the complaint and this notice and 
to enter an initial determination and a final determination containing 
such findings, and may result in the issuance of an exclusion order or 
a cease and desist order or both directed against the respondent.

    By order of the Commission.

    Issued: May 9, 2018.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2018-10240 Filed 5-14-18; 8:45 am]
 BILLING CODE 7020-02-P